Alexis French
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexis French has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Gary R. Maslow
4 shared publicationsKelley A. Jones
4 shared publicationsNaomi O. Davis
3 shared publications- Courtney L. McMickens
Duke University School of Medicine
2 shared publications - Melissa A. Greiner
Department of Population Health Sciences, Duke University School of Medicine , 215 Morris St, Durham, NC 27701, USA
2 shared publications Nicole Heilbron
2 shared publications
Latest Publications
- Open Access
- 20 March 2026
- Published by American Academy of Child and Adolescent Psychiatry in JAACAP Connect
- Vol. 13 (3)
Psychotropic Medication Use Among Children in Foster Care with Placement Instability: A Statewide Retrospective Analysis
This statewide retrospective analysis investigates the prevalence and patterns of high-risk psychotropic medication prescribing among children in foster care with placement instability. With 236 cases examined between June 2022 and June 2023, the study sought to identify sociodemographic differences in prescribing practices. Findings revealed that 37.3% of children in foster care received high-risk prescriptions, with no significant correlation to race or rurality. The results underscore the complex mental health needs of foster children, who are often subjected to medication regimens that include multiple psychotropics despite potential side effects and without thorough medical oversight. Recognizing the limitations inherent to retrospective data analysis, this study calls for further research to enhance understanding of high-risk prescribing for children with complex trauma in foster care.
- 20 March 2026
- Published by American Academy of Child and Adolescent Psychiatry in JAACAP Connect
- Vol. 13 (3)
Open AccessPsychotropic Medication Use Among Children in Foster Care with Placement Instability: A Statewide Retrospective Analysis
This statewide retrospective analysis investigates the prevalence and patterns of high-risk psychotropic medication prescribing among children in foster care with placement instability. With 236 cases examined between June 2022 and June 2023, the study sought to identify sociodemographic differences in prescribing practices. Findings revealed that 37.3% of children in foster care received high-risk prescriptions, with no significant correlation to race or rurality. The results underscore the complex mental health needs of foster children, who are often subjected to medication regimens that include multiple psychotropics despite potential side effects and without thorough medical oversight. Recognizing the limitations inherent to retrospective data analysis, this study calls for further research to enhance understanding of high-risk prescribing for children with complex trauma in foster care.
- Open Access
- 4 March 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13 (1) , e63740
Linking Electronic Health Record Prescribing Data and Pharmacy Dispensing Records to Identify Patient-Level Factors Associated With Psychotropic Medication Receipt: Retrospective Study
Background: Pharmacoepidemiology studies using electronic health record (EHR) data typically rely on medication prescriptions to determine which patients have received a medication. However, such data do not affirmatively indicate whether these prescriptions have been filled. External dispensing databases can bridge this information gap; however, few established methods exist for linking EHR data and pharmacy dispensing records. Objective: We described a process for linking EHR prescribing data with pharmacy dispensing records from Surescripts. As a use case, we considered the prescriptions and resulting fills for psychotropic medications among pediatric patients. We evaluated how dispensing information affects identifying patients receiving prescribed medications and assessing the association between filling prescriptions and subsequent health behaviors. Methods: This retrospective study identified all new psychotropic prescriptions to patients younger than 18 years of age at Duke University Health System in 2021. We linked dispensing to prescribing data using proximate dates and matching codes between RxNorm concept unique identifiers and National Drug Codes. We described demographic, clinical, and service use characteristics to assess differences between patients who did versus did not fill prescriptions. We fit a least absolute shrinkage and selection operator (LASSO) regression model to evaluate the predictability of a fill. We then fit time-to-event models to assess the association between whether a patient filled a prescription and a future provider visit. Results: We identified 1254 pediatric patients with a new psychotropic prescription. In total, 976 (77.8%) patients filled their prescriptions within 30 days of their prescribing encounters. Thus, we set 30 days as a cut point for defining a valid prescription fill. Patients who filled prescriptions differed from those who did not in several key factors. Those who did not fill had slightly higher BMIs, lived in more disadvantaged neighborhoods, were more likely to have public insurance or self-pay, and included a higher proportion of male patients. Patients with prior well-child visits or prescriptions from primary care providers were more likely to fill. Additionally, patients with anxiety diagnoses and those prescribed selective serotonin reuptake inhibitors were more likely to fill prescriptions. The LASSO model achieved an area under the receiver operator characteristic curve of 0.816. The time to the follow-up visit with the same provider was censored at 90 days after the initial encounter. Patients who filled prescriptions showed higher levels of follow-up visits. The marginal hazard ratio of a follow-up visit with the same provider was 1.673 (95% CI 1.463‐1.913) for patients who filled their prescriptions. Using the LASSO model as a propensity-based weight, we calculated the weighted hazard ratio as 1.447 (95% CI 1.257‐1.665). Conclusions: Systematic differences existed between patients who did versus did not fill prescriptions. Incorporating external dispensing databases into EHR-based studies informs medication receipt and associated health outcomes.
- 4 March 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13 (1) , e63740
Open AccessLinking Electronic Health Record Prescribing Data and Pharmacy Dispensing Records to Identify Patient-Level Factors Associated With Psychotropic Medication Receipt: Retrospective Study
Background: Pharmacoepidemiology studies using electronic health record (EHR) data typically rely on medication prescriptions to determine which patients have received a medication. However, such data do not affirmatively indicate whether these prescriptions have been filled. External dispensing databases can bridge this information gap; however, few established methods exist for linking EHR data and pharmacy dispensing records. Objective: We described a process for linking EHR prescribing data with pharmacy dispensing records from Surescripts. As a use case, we considered the prescriptions and resulting fills for psychotropic medications among pediatric patients. We evaluated how dispensing information affects identifying patients receiving prescribed medications and assessing the association between filling prescriptions and subsequent health behaviors. Methods: This retrospective study identified all new psychotropic prescriptions to patients younger than 18 years of age at Duke University Health System in 2021. We linked dispensing to prescribing data using proximate dates and matching codes between RxNorm concept unique identifiers and National Drug Codes. We described demographic, clinical, and service use characteristics to assess differences between patients who did versus did not fill prescriptions. We fit a least absolute shrinkage and selection operator (LASSO) regression model to evaluate the predictability of a fill. We then fit time-to-event models to assess the association between whether a patient filled a prescription and a future provider visit. Results: We identified 1254 pediatric patients with a new psychotropic prescription. In total, 976 (77.8%) patients filled their prescriptions within 30 days of their prescribing encounters. Thus, we set 30 days as a cut point for defining a valid prescription fill. Patients who filled prescriptions differed from those who did not in several key factors. Those who did not fill had slightly higher BMIs, lived in more disadvantaged neighborhoods, were more likely to have public insurance or self-pay, and included a higher proportion of male patients. Patients with prior well-child visits or prescriptions from primary care providers were more likely to fill. Additionally, patients with anxiety diagnoses and those prescribed selective serotonin reuptake inhibitors were more likely to fill prescriptions. The LASSO model achieved an area under the receiver operator characteristic curve of 0.816. The time to the follow-up visit with the same provider was censored at 90 days after the initial encounter. Patients who filled prescriptions showed higher levels of follow-up visits. The marginal hazard ratio of a follow-up visit with the same provider was 1.673 (95% CI 1.463‐1.913) for patients who filled their prescriptions. Using the LASSO model as a propensity-based weight, we calculated the weighted hazard ratio as 1.447 (95% CI 1.257‐1.665). Conclusions: Systematic differences existed between patients who did versus did not fill prescriptions. Incorporating external dispensing databases into EHR-based studies informs medication receipt and associated health outcomes.
- Open Access
- 17 September 2024
- Published by North Carolina Institute of Medicine in North Carolina Medical Journal
- Vol. 85 (5) , 322-328
Behavioral Health Trends Among Perinatal North Carolina Medicaid Beneficiaries
Untreated behavioral health conditions among the perinatal population are associated with high mortality and morbidity. We examined trends of behavioral health conditions and treatment received by perinatal Medicaid beneficiaries and described the characteristics of providers treating these beneficiaries from 2017 to 2022. Results indicated that 24.4% of beneficiaries had a behavioral health diagnosis, 13.8% received a psychotropic prescription, and 7.1% received a behavioral health service.
- 17 September 2024
- Published by North Carolina Institute of Medicine in North Carolina Medical Journal
- Vol. 85 (5) , 322-328
Open AccessBehavioral Health Trends Among Perinatal North Carolina Medicaid Beneficiaries
Untreated behavioral health conditions among the perinatal population are associated with high mortality and morbidity. We examined trends of behavioral health conditions and treatment received by perinatal Medicaid beneficiaries and described the characteristics of providers treating these beneficiaries from 2017 to 2022. Results indicated that 24.4% of beneficiaries had a behavioral health diagnosis, 13.8% received a psychotropic prescription, and 7.1% received a behavioral health service.
- 16 August 2023
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- Vol. 11 (5) , 2663-2675
Telehealth Utilization Among Adult Medicaid Beneficiaries in North Carolina with Behavioral Health Conditions During the COVID-19 Pandemic
Objective We examined factors associated with telehealth utilization during COVID-19 among adult Medicaid beneficiaries with behavioral health conditions. Data Sources and Study Setting NC Medicaid 2019–2021 beneficiary and claims data. Study Design This retrospective cohort study examined and compared behavioral health service use pre-COVID-19 (03/01/2019 to 02/28/2020) and during COVID-19 (04/01/2020 to 03/31/2021). Telehealth users included those with at least one behavioral health visit via telehealth during COVID-19. Descriptive statistics were calculated for overall sample and by telehealth status. Multilevel modified Poisson generalized estimating equation examined associations between telehealth use and patient- and area-level characteristics. Data Collection/Extraction Methods We identified individuals ages ≥ 21–64, diagnosed with a behavioral health condition, and had at least one behavioral-health specific visit before COVID-19. Principal Findings Almost two-thirds of the cohort received behavioral health services during COVID-19, with half of these beneficiaries using telehealth. Non-telehealth users had steeper declines in service use from pre- to during COVID-19 compared to telehealth users. Beneficiaries identifying as Black, multiracial or other were significantly less likely to use telehealth (ARR = 0.86; 95% CI: (0.83, 0.89)); (ARR = 0.92; 95% CI: (0.87, 0.96)) compared to White beneficiaries. Those eligible for Medicaid through the blind/disabled programs and who qualified for a state-specific specialized behavioral health plan were more likely to use telehealth (17% and 20%, respectively). Conclusions During the pandemic, telehealth facilitated continuity of care for beneficiaries with behavioral health conditions. Future research should aim to investigate how to reduce the digital divide and ensure equitable access to telehealth.
- 16 August 2023
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- Vol. 11 (5) , 2663-2675
Telehealth Utilization Among Adult Medicaid Beneficiaries in North Carolina with Behavioral Health Conditions During the COVID-19 Pandemic
Objective We examined factors associated with telehealth utilization during COVID-19 among adult Medicaid beneficiaries with behavioral health conditions. Data Sources and Study Setting NC Medicaid 2019–2021 beneficiary and claims data. Study Design This retrospective cohort study examined and compared behavioral health service use pre-COVID-19 (03/01/2019 to 02/28/2020) and during COVID-19 (04/01/2020 to 03/31/2021). Telehealth users included those with at least one behavioral health visit via telehealth during COVID-19. Descriptive statistics were calculated for overall sample and by telehealth status. Multilevel modified Poisson generalized estimating equation examined associations between telehealth use and patient- and area-level characteristics. Data Collection/Extraction Methods We identified individuals ages ≥ 21–64, diagnosed with a behavioral health condition, and had at least one behavioral-health specific visit before COVID-19. Principal Findings Almost two-thirds of the cohort received behavioral health services during COVID-19, with half of these beneficiaries using telehealth. Non-telehealth users had steeper declines in service use from pre- to during COVID-19 compared to telehealth users. Beneficiaries identifying as Black, multiracial or other were significantly less likely to use telehealth (ARR = 0.86; 95% CI: (0.83, 0.89)); (ARR = 0.92; 95% CI: (0.87, 0.96)) compared to White beneficiaries. Those eligible for Medicaid through the blind/disabled programs and who qualified for a state-specific specialized behavioral health plan were more likely to use telehealth (17% and 20%, respectively). Conclusions During the pandemic, telehealth facilitated continuity of care for beneficiaries with behavioral health conditions. Future research should aim to investigate how to reduce the digital divide and ensure equitable access to telehealth.
- Open Access
- 4 July 2023
- Published by Elsevier in JAACAP Open
- Vol. 1 (3) , 196-205
Treatment and Outcomes Among North Carolina Medicaid-Insured Youth With Depression
- 4 July 2023
- Published by Elsevier in JAACAP Open
- Vol. 1 (3) , 196-205
Open AccessTreatment and Outcomes Among North Carolina Medicaid-Insured Youth With Depression
- 1 December 2022
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 73 (12) , 1401-1404
Racial and Ethnic Differences in Psychotropic Prescription Receipt Among Pediatric Patients Enrolled in North Carolina Medicaid
Objective: The authors aimed to examine racial-ethnic differences in filled psychotropic prescriptions among a pediatric Medicaid population. Methods: This retrospective cohort study included patients ages 0–21 with at least one North Carolina Medicaid claim from October 1, 2017, through September 30, 2018 (N=983,886). The primary outcome was a filled psychotropic prescription. Separate multivariable modified Poisson regression models generated adjusted risk ratios (ARRs) and 95% confidence intervals (CIs), adjusted for patient demographic characteristics. Results: Black and Hispanic patients were significantly less likely to receive any filled psychotropic prescription (ARR=0.61, 95% CI=0.60–0.62; ARR=0.29, 95% CI=0.28–0.29, respectively) compared with White and non-Hispanic patients. Furthermore, Black and Hispanic patients were less likely to receive filled prescriptions in the four included drug classes compared with White and non-Hispanic patients. Conclusions: Future studies should focus on understanding the factors contributing to racial and ethnic differences among pediatric patients receiving filled psychotropic prescriptions.
- 1 December 2022
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 73 (12) , 1401-1404
Racial and Ethnic Differences in Psychotropic Prescription Receipt Among Pediatric Patients Enrolled in North Carolina Medicaid
Objective: The authors aimed to examine racial-ethnic differences in filled psychotropic prescriptions among a pediatric Medicaid population. Methods: This retrospective cohort study included patients ages 0–21 with at least one North Carolina Medicaid claim from October 1, 2017, through September 30, 2018 (N=983,886). The primary outcome was a filled psychotropic prescription. Separate multivariable modified Poisson regression models generated adjusted risk ratios (ARRs) and 95% confidence intervals (CIs), adjusted for patient demographic characteristics. Results: Black and Hispanic patients were significantly less likely to receive any filled psychotropic prescription (ARR=0.61, 95% CI=0.60–0.62; ARR=0.29, 95% CI=0.28–0.29, respectively) compared with White and non-Hispanic patients. Furthermore, Black and Hispanic patients were less likely to receive filled prescriptions in the four included drug classes compared with White and non-Hispanic patients. Conclusions: Future studies should focus on understanding the factors contributing to racial and ethnic differences among pediatric patients receiving filled psychotropic prescriptions.
- Open Access
- 30 March 2022
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
- Vol. 43 (7) , 393-401
Inequities in Receipt of the North Carolina Medicaid Waiver Among Individuals with Intellectual Disability or Autism Spectrum Disorder
Objective: We examined characteristics associated with receiving the North Carolina Home and Community-Based Services Waiver for intellectual and developmental disabilities (I/DDs) and its association with emergency department (ED) utilization. Method: Through analysis of the North Carolina 2017 to 2018 Medicaid claims and enrollment data, we examined characteristics (age, sex, race and ethnicity, geography, diagnosis (intellectual disability [ID] with or without autism spectrum disorders or autism spectrum disorder without ID) associated with receiving the NC I/DD Waiver and the association of this Wavier with ED utilization. We identified patients with at least 1 International Classification of Diseases-10-CM diagnosis code for an ID or autism spectrum disorder. We excluded patients with missing county information and whose enrollment in the NC I/DD Waiver program began after October 1, 2017. Results: Only 22% of 53,531 individuals with I/DD in North Carolina received the Waiver. Non-Hispanic Blacks and Hispanic individuals were less likely to receive the Waiver than non-Hispanic White individuals. Adults (>21 years old), men, and urban residents were more likely to receive the Waiver. Individuals who received the Waiver were 31% less likely to use the ED. Conclusion: Innovative strategies are needed to provide equitable access to the NC I/DD Waiver and provide services to the 14,000 people with I/DD currently waiting to receive the Waiver. Through the Waiver, those with I/DD can access preventative and therapeutic outpatient services and decrease their need for ED care. These findings highlight the need for policy reform to address inequities in access to the Waiver for individuals with I/DD.
- 30 March 2022
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
- Vol. 43 (7) , 393-401
Open AccessInequities in Receipt of the North Carolina Medicaid Waiver Among Individuals with Intellectual Disability or Autism Spectrum Disorder
Objective: We examined characteristics associated with receiving the North Carolina Home and Community-Based Services Waiver for intellectual and developmental disabilities (I/DDs) and its association with emergency department (ED) utilization. Method: Through analysis of the North Carolina 2017 to 2018 Medicaid claims and enrollment data, we examined characteristics (age, sex, race and ethnicity, geography, diagnosis (intellectual disability [ID] with or without autism spectrum disorders or autism spectrum disorder without ID) associated with receiving the NC I/DD Waiver and the association of this Wavier with ED utilization. We identified patients with at least 1 International Classification of Diseases-10-CM diagnosis code for an ID or autism spectrum disorder. We excluded patients with missing county information and whose enrollment in the NC I/DD Waiver program began after October 1, 2017. Results: Only 22% of 53,531 individuals with I/DD in North Carolina received the Waiver. Non-Hispanic Blacks and Hispanic individuals were less likely to receive the Waiver than non-Hispanic White individuals. Adults (>21 years old), men, and urban residents were more likely to receive the Waiver. Individuals who received the Waiver were 31% less likely to use the ED. Conclusion: Innovative strategies are needed to provide equitable access to the NC I/DD Waiver and provide services to the 14,000 people with I/DD currently waiting to receive the Waiver. Through the Waiver, those with I/DD can access preventative and therapeutic outpatient services and decrease their need for ED care. These findings highlight the need for policy reform to address inequities in access to the Waiver for individuals with I/DD.